STAT+: Pharmalittle: We're reading about Moderna's $2.25 billion settlement, FDA warning letters, and more

Moderna settled a patent infringement lawsuit with Roivant for up to $2.25 billion, avoiding an upcoming jury trial and providing financial relief for Roivant; Virginia lawmakers are proposing an affordability board that will use Medicare as a benchmark to contain prescription drug costs, potentially setting new standards in drug pricing regulation. For content creators, these developments highlight the ongoing legal and regulatory challenges in the pharmaceutical industry, emphasizing the importance of staying informed about patent disputes and policy changes affecting drug pricing.

Read the full article at STAT Pharma

---

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.